Follow
Emmanuel Katsanis, M.D.
Emmanuel Katsanis, M.D.
Verified email at peds.arizona.edu - Homepage
Title
Cited by
Cited by
Year
Doxorubicin eliminates myeloid-derived suppressor cells and enhances the efficacy of adoptive T-cell transfer in breast cancer
D Alizadeh, M Trad, NT Hanke, CB Larmonier, N Janikashvili, B Bonnotte, ...
Cancer research 74 (1), 104-118, 2014
4002014
CD4+ CD25+ FoxP3+ regulatory T cells suppress Mycobacterium tuberculosis immunity in patients with active disease
X Chen, B Zhou, M Li, Q Deng, X Wu, X Le, C Wu, N Larmonier, W Zhang, ...
Clinical immunology 123 (1), 50-59, 2007
3782007
Tumor-derived CD4+CD25+ regulatory T cell suppression of dendritic cell function involves TGF-β and IL-10
N Larmonier, M Marron, Y Zeng, J Cantrell, A Romanoski, M Sepassi, ...
Cancer Immunology, Immunotherapy 56, 48-59, 2007
3202007
Molecular chaperones: biology and prospects for pharmacological intervention
DF Smith, L Whitesell, E Katsanis
Pharmacological reviews 50 (4), 493-514, 1998
3051998
The immunological case for staying active during the COVID-19 pandemic
RJ Simpson, E Katsanis
Brain, behavior, and immunity 87, 6-7, 2020
2522020
Stressed apoptotic tumor cells stimulate dendritic cells and induce specific cytotoxic T cells
H Feng, Y Zeng, MW Graner, E Katsanis
Blood, The Journal of the American Society of Hematology 100 (12), 4108-4115, 2002
2262002
Stressed apoptotic tumor cells express heat shock proteins and elicit tumor-specific immunity
H Feng, Y Zeng, L Whitesell, E Katsanis
Blood, The Journal of the American Society of Hematology 97 (11), 3505-3512, 2001
2082001
Invasion and metastasis of a mammary tumor involves TGF‐β signaling
JA McEarchern, JJ Kobie, V Mack, RS Wu, L Meade‐Tollin, CL Arteaga, ...
International journal of cancer 91 (1), 76-82, 2001
2072001
Imatinib mesylate inhibits CD4+ CD25+ regulatory T cell activity and enhances active immunotherapy against BCR-ABL− tumors
N Larmonier, N Janikashvili, CJ LaCasse, CB Larmonier, J Cantrell, ...
The Journal of Immunology 181 (10), 6955-6963, 2008
1882008
Interleukin‐2 liposome inhalation therapy is safe and effective for dogs with spontaneous pulmonary metastases
C Khanna, PM Anderson, DE Hasz, E Katsanis, M Neville, JS Klausner
Cancer 79 (7), 1409-1421, 1997
1581997
The complex pathophysiology of acquired aplastic anaemia
Y Zeng, E Katsanis
Clinical & Experimental Immunology 180 (3), 361-370, 2015
1522015
Influenza in children with cancer
A Kempe, CB Hall, NE MacDonald, HR Foye, KA Woodin, HJ Cohen, ...
The Journal of pediatrics 115 (1), 33-39, 1989
1411989
Exogenous stress proteins enhance the immunogenicity of apoptotic tumor cells and stimulate antitumor immunity
H Feng, Y Zeng, MW Graner, A Likhacheva, E Katsanis
Blood, The Journal of the American Society of Hematology 101 (1), 245-252, 2003
1382003
Exercise as a countermeasure for latent viral reactivation during long duration space flight
NH Agha, SK Mehta, BV Rooney, MS Laughlin, MM Markofski, DL Pierson, ...
The FASEB Journal 34 (2), 2869-2881, 2020
1362020
Low dose subcutaneous interleukin-2 after autologous transplantation generates sustained in vivo natural killer cell activity.
JS Miller, J Tessmer-Tuck, BA Pierson, D Weisdorf, P McGlave, BR Blazar, ...
Biology of blood and marrow transplantation: journal of the American Society …, 1997
1361997
Immunologic effects of rituximab on the human spleen in immune thrombocytopenia
S Audia, M Samson, J Guy, N Janikashvili, J Fraszczak, M Trad, M Ciudad, ...
Blood, The Journal of the American Society of Hematology 118 (16), 4394-4400, 2011
1342011
Tumor-derived, chaperone-rich cell lysate activates dendritic cells and elicits potent antitumor immunity
Y Zeng, H Feng, MW Graner, E Katsanis
Blood 101 (11), 4485-4491, 2003
1202003
Unrelated donor bone marrow transplantation for children with acute leukemia.
SM Davies, JE Wagner, XO Shu, BR Blazar, E Katsanis, PJ Orchard, ...
Journal of clinical oncology 15 (2), 557-565, 1997
1191997
β2-Adrenergic receptor signaling mediates the preferential mobilization of differentiated subsets of CD8+ T-cells, NK-cells and non-classical monocytes in response to acute …
RM Graff, HE Kunz, NH Agha, FL Baker, M Laughlin, AB Bigley, ...
Brain, behavior, and immunity 74, 143-153, 2018
1182018
Tumor-derived chaperone-rich cell lysates are effective therapeutic vaccines against a variety of cancers
MW Graner, Y Zeng, H Feng, E Katsanis
Cancer Immunology, Immunotherapy 52, 226-234, 2003
1062003
The system can't perform the operation now. Try again later.
Articles 1–20